2016 Translational Imaging Symposium for Drug Discovery and Development
District Hall, 75 Northern Avenue, Boston, MA 02210
May 12, 2016
Leaders in translational molecular imaging will be presenting on the latest innovations and emerging global trends in the field. At inviCRO’s first Translational Imaging Symposium in 2014, over 130 image scientists attended presentations by top experts from both industry and academia on topics ranging from therapeutic- and modality-specific imaging approaches to more general industry strategies for advancing drug candidates into the clinic. We look forward to hosting another event which will provide a forum for thought-leaders in translational imaging to share insights into the latest advancements in the field.
Registration and Breakfast 7:30 am – 8:15 am
Speakers 8:15 am – 4:50 pm
Exhibit Hall Open 7:30 am – 3:15 pm
Reception 4:50 pm to 7:00 pm
Symposium presentations from experts in the field include:
Smarter Drug Discovery Using Imaging Biomarkers
Richard Hargreaves, PhD, HonFBPhS, VP Neuropharmacology & Head Global Biomarker Discovery and Development, Biogen
Tau PET Imaging: A Potential Paradigm Shift in Alzheimer’s Disease Drug Development
Eric Hostetler, Executive Director, Head of Translational Imaging, Merck & Co., Inc.
Driving Pre-clinical Decisions: The role of imaging
Christopher T. Winkelmann, DVM, PhD, Associate Research Fellow, Pfizer
Novel PET Imaging Strategies for Improving Detection and Treatment of Neurological Diseases
Michelle L. James, PhD, Instructor, Department of Radiology and Department of Neurology & Neurological Sciences, Stanford University School of Medicine
Evaluating the Biodistribution of Biologics using Molecular Imaging
John Beaver, PhD, Head, Translational Imaging & Volwiler Research Fellow, AbbVie
Optimizing Image-guided Alpha Particle Therapy for Metastatic Melanoma – New Ideas for Reducing Kidney Dose
Michael Schultz, Associate Professor, the University of Iowa
Discovery and Optimization of Tracer Ligands for CNS PET Imaging
Huikai Sun, PhD, Takeda
Update on Tau and Amyloid Imaging in Alzheimers: How do they relate?
Mark A. Mintun, MD, Chief Medical Officer, Avid Radiopharmaceuticals, Inc.
Other speakers include:
Ken Marek, MD of Molecular NeuroImaging (MNI), a division of inviCRO and Ajay Verma of Biogen
Registration is free of charge. Complimentary breakfast and lunch will be provided. A reception with drinks and appetizers will follow the meeting from 5:00 pm to 7:00 pm. Please check back for more details about the program, invited speakers and agenda as they become available.
District Hall, 75 Northern Avenue, Boston, MA 02210.
Renaissance Hotel, 606 Congress Street Boston Massachusetts 02210
The nearby Renaissance Hotel is offering a fixed rate for the night of May 11th to Symposium guests who book by April 27th. Reserve your room at the Rennaissance Hotel.
Seaport Hotel and World Trade Center, 200 Seaport Blvd, Boston, MA 02210
This modern hotel and business complex overlooking Boston Harbor is 0.2 miles from the District Hall.
The Westin Boston Waterfront, 425 Summer Street, Boston, MA, 02210
Adjacent to the Boston Convention and Exhibition Center, this contemporary hotel with a vertical garden in the lobby is 0.6 miles from the District Hall.